Pharmaceutical Technology - October 2022

e B O O K S E R I E S TRENDS IN FORMULATION O C T O B E R 2 0 2 2 CPHI Frankfurt Show Guide Quality Biologics Formulation and Drug Delivery Development

• PTeBook1022_001_Cover
• PTebook1022_002_TOCMasthead
• PTeBook1022_Ads
• PTebook1022_004-009_EarlyDevelopment_DrugCandidateScreening_Mirasol
• PTeBook1022_Ads (1)
• PTebook1022_004-009_EarlyDevelopment_DrugCandidateScreening_Mirasol (1)
• PTeBook1022_Ads (2)
• PTebook1022_004-009_EarlyDevelopment_DrugCandidateScreening_Mirasol (2)
• PTebook1022_010-013_DrugDelivery_Nanoparticle_Nanoform
• PTeBook1022_Ads (3)
• PTebook1022_010-013_DrugDelivery_Nanoparticle_Nanoform (1)
• PTebook1022_014-018_MachineLearning_Spivey
• PTeBook1022_Ads (4)
• PTebook1022_014-018_MachineLearning_Spivey (1)
• PTeBook1022_Ads (5)
• PTebook1022_014-018_MachineLearning_Spivey (2)
• PTeBook1022_Ads (6)
• PTebook1022_020-028_DrugDelivery_TPGS_Antares
• PTeBook1022_Ads (7)
• PTebook1022_020-028_DrugDelivery_TPGS_Antares (1)
• PTeBook1022_Ads (8)
• PTebook1022_020-028_DrugDelivery_TPGS_Antares (2)
• PTeBook1022_Ads (9)
• PTebook1022_030-035_DrugDelivery_DryPowder_Williams
• PTeBook1022_Ads (10)
• PTebook1022_030-035_DrugDelivery_DryPowder_Williams (1)
• PTeBook1022_Ads (11)
• PTebook1022_030-035_DrugDelivery_DryPowder_Williams (2)
• PTebook1022_036-040_Biologics_ViralVectors_Avantor
• PTeBook1022_Ads (12)
• PTebook1022_036-040_Biologics_ViralVectors_Avantor (1)
• PTeBook1022_Ads (13)
• PTeBook1022_042-050_Quality_Nitrosamides_Srinivasan
• PTeBook1022_Ads (14)
• PTeBook1022_042-050_Quality_Nitrosamides_Srinivasan (1)
• PTeBook1022_Ads (15)
• PTeBook1022_042-050_Quality_Nitrosamides_Srinivasan (2)
• PTeBook1022_Ads (16)
• PTeBook1022_042-050_Quality_Nitrosamides_Srinivasan (3)
• PTeBook1022_Ads (17)
• PTeBook1022_042-050_Quality_Nitrosamides_Srinivasan (4)
• PTeBook1022_Ads (18)
• PTeBook1022_052-054_GMPs_Solid Dosge_Spivey
• PTeBook1022_055_CPHI-Cover
• PTeBook1022_056-059_CPHI Interview
• PTebook1022_060-065_CPHI-Profiles
• PTeBook1022_Ads (19)